Applications of 3-Bromopyridine-2-Carboxylic Acid in Industrial Manufacturing

As an established producer of 3-Bromopyridine-2-Carboxylic Acid, we directly support advanced manufacturing needs across strictly defined, technically demanding downstream industries. Our compliance-driven production and controlled process integration result in high-conformity intermediates vital for pharmaceutical actives, agricultural research, and specialty chemical synthesis. Below are the leading industrial applications of this raw material, structured for buyer technical review and traceability.

1. Pharmaceutical API Intermediate Synthesis

3-Bromopyridine-2-Carboxylic Acid serves as a crucial building block in the synthesis of various active pharmaceutical ingredients (APIs), particularly for anti-infective agents and CNS drugs. The halogenated pyridine ring in this molecule enables specific selective functionalization steps in multi-stage pharmachemical production. Downstream manufacturers integrate this intermediate after initial coupling reactions to construct core structures of innovative APIs, with usage ratios finely tuned according to target yield, step economy, and impurity profile management.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP-NF, EP, and JP relevant monograph specifications for intermediates
• 21 CFR Part 211 for finished pharmaceuticals (impact on traceability)
• REACH Annex XVII for chemical handling and employee safety

Typical usage ratio

• 0.5–1.8 molar equivalents relative to the primary nucleus in the reaction, adjusted for step yield and downstream transformation efficiency

Downstream process integration

• Reacted in palladium-catalyzed coupling or amination procedures following carboxylic activation in the synthetic route, often in second or third key intermediate stage

Final product types

• Cephalosporin and quinolone antibiotic cores
• Pyridine-based CNS drug scaffolds
• Specialty antivirals in early clinical-stage development

2. Agrochemical Compound Development

Leading agrochemical developers incorporate 3-Bromopyridine-2-Carboxylic Acid for manufacturing herbicide and fungicide precursor molecules. Its bromopyridine structure introduces selectivity and metabolism-resistant features essential to novel crop protection agents. The raw material is precisely dosed in the acylation or aromatic substitution stages following initial ring formation, ensuring accurate building block assembly for proprietary agrochemical candidates.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• OECD Principles of Good Laboratory Practice
• REACH registration and authorization for agro-inputs
• ISO 9001:2015 for quality management in synthesis scale-up

Typical usage ratio

• 1.0–2.2% (w/w) of total batch mass in intermediate synthesis, ratios optimized per specific molecular design

Downstream process integration

• Introduced into Grignard or Suzuki reaction steps after protection group manipulation, central for ring construction in selective herbicide and fungicide actives

Final product types

• Pyridine-derived pre-emergent herbicide actives
• Fungicidal treatments for cereal and oilseed crops
• Research-stage insecticide molecular scaffolds

3. Specialty Dye and Pigment Intermediate

Manufacturers in the colorant industry utilize 3-Bromopyridine-2-Carboxylic Acid as a unique backbone for synthesizing tailored pyridyl dyes, notably when formulating lightfast pigments for sensitive coating applications. The acid’s controlled reactivity under electrophilic aromatic coupling fosters precise chromophore fine-tuning unavailable via classical aromatic acids. Addition occurs just prior to the condensation stage to guarantee desired pigment structure and stability.

Industry compliance standards

• EN 71-3:2019 for pigment migration in toys and coatings
• ISO 18451-1:2019 for pigment composition declaration
• Oeko-Tex Standard 100 (textile applications)
• REACH compliance for industrial pigments

Typical usage ratio

• 3–12% by weight of colorant precursor matrix; adjusted based on target absorption spectrum and required color stability

Downstream process integration

• Added immediately preceding azo condensation, under controlled temperature and base conditions for selective functional group preservation

Final product types

• Specialty color lakes for inks and coatings
• Non-migratory pigments for food-contact packaging
• Photostable textile printing dyes

4. Electronic Chemical Synthesis (OLED Material Precursors)

Advanced materials manufacturers employ 3-Bromopyridine-2-Carboxylic Acid in the controlled assembly of electron-transport and host structures for organic light-emitting diode displays (OLEDs). Its defined heteroaromatic substitution pattern underpins critical charge balance and emission tuning properties in finished materials. Entry to the process stage typically follows ring closure, enabling subsequent cross-coupling to multi-ring OLED precursors at high purity levels demanded by electronic applications.

Industry compliance standards

• JEITA EM-3604 guidelines for organic electronic material quality
• RoHS Directive 2011/65/EU compliance
• QC/QA protocols for low-ion contaminant specifications (ppb range)
• ISO 14001:2015 for environmental management in electronics chemicals

Typical usage ratio

• 0.2–1.0% by final OLED material weight; determined via target device performance, quantum efficiency, and emission wavelength

Downstream process integration

• Applied post-core synthesis as a coupling partner in Buchwald-Hartwig or Suzuki-Miyaura reactions, driving assembly of OLED host or dopant structures

Final product types

• Blue and green OLED host compounds
• Electron-transport layers for flexible displays
• Advanced photoconductor intermediates

5. Veterinary Drug Intermediate Production

3-Bromopyridine-2-Carboxylic Acid functions as a tailored intermediate for new-generation veterinary active ingredients, notably for oral and injectable formulations targeting livestock and companion animals. Its molecular profile enables formation of specialized derivatives through nucleophilic substitution, contributing to pharmacological profiles such as improved metabolic stability and animal safety. The compound is incorporated following initial heterocycle assembly, ahead of final pharmacophore coupling.

Industry compliance standards

• VICH GL10 GMP for Active Pharmaceutical Ingredients used in Veterinary Medicinal Products
• Ph. Eur. and USP guidelines on veterinary intermediates
• FSMA (21 CFR 507) for animal feed applications
• GMP+ Feed Safety Assurance Modules (for indirect feed drug intermediates)

Typical usage ratio

• 0.9–1.6 molar equivalents against primary core; precise ratio governed by desired yields and impurity limits imposed by final veterinary API specs

Downstream process integration

• Engaged in halide exchange prior to heterocycle extension, then processed in final coupling or amidation steps ahead of API crystallization

Final product types

• Anaplasmosis and antiparasitic veterinary actives
• Livestock injectable formulation intermediates
• Companion animal oral drug scaffolds